Statins IN TREATMENT OF ACUTE coronary syndrome. COMPARISON OF EFFICACY BETWEEN Atorvastatin and Rosuvastatin IN PATIENTS UNDERGO A PTCA THROUGH THE MONITORING OF C REACTIVE PROTEIN - ND
- Conditions
- MedDRA version: 9.1Level: SOCClassification code 10007541MedDRA version: 9.1Level: HLTClassification code 10011085Patients with Acute coronary syndrome without up-leveling of ST line.
- Registration Number
- EUCTR2009-012850-19-IT
- Lead Sponsor
- AZIENDA SANITARIA LOCALE DI BARI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Included patients aged from 18th to 80anni diagnosed with NSTE-SCA values and HS-PCR> 2 mg / dl.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Will be excluded all patients who have one of the following medical conditions:
Diabetes mellitus
Smokers and former smokers from ≤ 10 aa
note dyslipidemia (LDL cholesterol ≥ 160 mg / dL or Trigliceridemia ≥ 150 mg / dl) and / or drug treatment
known coronary artery disease
Pregnancy or breastfeeding
Chronic renal insufficiency (creatinine> 2.2 mg / dl or GFR-glomerular filtration-calculated with the formula of Cockroft and Gault, 30ml/min)
Hepatic impairment
Infectious Diseases and / or acute inflammatory conditions in place and / or chronic
active or malignant neoplasia in history
innate or acquired immune deficiency
cerca
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method